Patent · US Active

Hetero-bicyclic derivatives as HCV inhibitors

US8815849B2 · kind B2 · utility

1Cited by

0References

11Claims

0Family size

Assignee

Janssen R & D Ireland · IE

Inventors

Koen Vandyck · Beringen, BE
Wim Gaston Verschueren · Berchem, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE

Key dates

Filing date	Jul 26, 2011
Grant date	Aug 26, 2014
Priority date	—
Expiry date	Jul 26, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of HCV replication of formula Iincluding stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R′ have the meaning as defined herein.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.